Comparisons of Serum Vitamin D Levels, Status, and Determinants in Populations With and Without Chronic Kidney Disease Not Requiring Renal Dialysis: A 24-Hour Urine Collection Population-Based Study

Journal of Renal Nutrition

Volumn 24, Issue 5, 2014, Pages 303-312

  Guessous, Idris ^a,b,c   McClellan, William ^c   Kleinbaum, David ^c   Vaccarino, Viola ^c   Zoller, Otmar ^d   Theler, Jean Marc ^a   Paccaud, Fred ^b   Burnier, Michel ^e   Bochud, Murielle ^b  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c EMORY UNIVERSITY   (United States)

^d Federal Food Safety and Veterinary Office   (Switzerland)

^e UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84903862413     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2014.04.005     Document Type: Article

References (40)

1. Llach F., Yudd M. Pathogenic, clinical, and therapeutic aspects of secondary hyperparathyroidism in chronic renal failure. Am J Kidney Dis 1998, 32(suppl 2):S3-S12.
2. Sato K.A., Gray R.W., Lemann J. Urinary excretion of 25-hydroxyvitamin D in health and the nephrotic syndrome. J Lab Clin Med 1982, 99:325-330.
3. Krajisnik T., Bjorklund P., Marsell R., et al. Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells. J Endocrinol 2007, 195:125-131.
4. National Kidney Foundation K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003, 42(suppl 3):S1-S201.
5. Al-Badr W., Martin K.J. Vitamin D and kidney disease. Clin J Am Soc Nephrol 2008, 3:1555-1560.
6. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl 2009, S1-S130.
7. Holick M.F. Vitamin D deficiency. N Engl J Med 2007, 357:266-281.
8. Ross A.C., Manson J.E., Abrams S.A., et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 2011, 96:53-58.
9. de Boer I.H., Ioannou G.N., Kestenbaum B., et al. 25-Hydroxyvitamin D levels and albuminuria in the Third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis 2007, 50:69-77.
10. Damasiewicz M.J., Magliano D.J., Daly R.M., et al. 25-Hydroxyvitamin D levels and chronic kidney disease in the AusDiab (Australian Diabetes, Obesity and Lifestyle) study. BMC Nephrol 2012, 13:55.
11. Isakova T., Gutierrez O.M., Patel N.M., et al. Vitamin D deficiency, inflammation, and albuminuria in chronic kidney disease: complex interactions. J Ren Nutr 2011, 21:295-302.
12. Patel S., Barron J.L., Mirzazedeh M., et al. Changes in bone mineral parameters, vitamin D metabolites, and PTH measurements with varying chronic kidney disease stages. J Bone Miner Metab 2011, 29:71-79.
13. Levin A., Bakris G.L., Molitch M., et al. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int 2007, 71:31-38.
14. Chonchol M., Scragg R. 25-Hydroxyvitamin D, insulin resistance, and kidney function in the Third National Health and Nutrition Examination Survey. Kidney Int 2007, 71:134-139.
15. de Boer I.H., Katz R., Chonchol M., et al. Serum 25-hydroxyvitamin D and change in estimated glomerular filtration rate. Clin J Am Soc Nephrol 2011, 6:2141-2149.
16. Oh Y.J., Kim M., Lee H., et al. A threshold value of estimated glomerular filtration rate that predicts changes in serum 25-hydroxyvitamin D levels: 4th Korean National Health and Nutritional Examination Survey 2008. Nephrol Dial Transplant 2012, 27:2396-2403.
17. Mehrotra R., Kermah D., Budoff M., et al. Hypovitaminosis D in chronic kidney disease. Clin J Am Soc Nephrol 2008, 3:1144-1151.
18. Cuppari L., Garcia-Lopes M.G. Hypovitaminosis D in chronic kidney disease patients: prevalence and treatment. J Ren Nutr 2009, 19:38-43.
19. Guessous I., Dudler V., Glatz N., et al. Vitamin D levels and associated factors: a population-based study in Switzerland. Swiss Med Wkly 2012, 142:0.
20. Chappuis A, Bochud M, Glatz N, Vuistiner P, Paccaud F, Burnier M. Swiss Survey on Salt Intake: main results. Accessed May 28 2014. http://www.bag.admin.ch/themen/ernaehrung_bewegung/.
21. Levey A.S., Stevens L.A., Schmid C.H., et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009, 150:604-612.
22. El Assaad M.A., Topouchian J.A., Darne B.M., et al. Validation of the Omron HEM-907 device for blood pressure measurement. Blood Press Monit 2002, 7:237-241.
23. Yetley E.A., Pfeiffer C.M., Schleicher R.L., et al. NHANES monitoring of serum 25-hydroxyvitamin D: a roundtable summary. J Nutr 2010, 140:2030S-2045S.
24. de la Hunty A., Wallace A.M., Gibson S., et al. UK Food Standards Agency Workshop Consensus Report: the choice of method for measuring 25-hydroxyvitamin D to estimate vitamin D status for the UK National Diet and Nutrition Survey. Br J Nutr 2010, 104:612-619.
25. National Institute of Standards and Technology (NIST) Certificate of Analysis, Standard Reference Material 972, Vitamin D in Human Serum 2009, NIST, Gaithersburg, MD, Accessed May 28 2014. https://www-s.nist.gov/srmors/certificates/972.pdf.
26. Heeringa S., West B., Berglund P. Applied Survey Data Analysis 2010, Chapman & Hall/CRC, Boca Raton, FL.
27. CDC. NHANES Web Tutorials. Avaialble at:. Accessed May 28 2014. http://www.cdc.gov/nchs/tutorials/NHANES/NHANESAnalyses/hypothesistesting/hypothesis_testing_intro.htm.
28. Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 2001, 22:477-501.
29. Looker A.C., Pfeiffer C.M., Lacher D.A., et al. Serum 25-hydroxyvitamin D status of the US population: 1988-1994 compared with 2000-2004. Am J Clin Nutr 2008, 88:1519-1527.
30. Lips P. Vitamin D physiology. Prog Biophys Mol Biol 2006, 92:4-8.
31. Kimlin M.G. Geographic location and vitamin D synthesis. Mol Aspects Med 2008, 29:453-461.
32. Bosworth C.R., Levin G., Robinson-Cohen C., et al. The serum 24,25-dihydroxyvitamin D concentration, a marker of vitamin D catabolism, is reduced in chronic kidney disease. Kidney Int 2012, 82:693-700.
33. Pilz S., Iodice S., Zittermann A., et al. Vitamin D status and mortality risk inCKD: a meta-analysis of prospective studies. Am J Kidney Dis 2011, 58:374-382.
34. Schottker B., Ball D., Gellert C., et al. Serum 25-hydroxyvitamin D levels and overall mortality. A systematic review and meta-analysis of prospective cohort studies. Ageing Res Rev 2012, 2:708-718.
35. Ginde A.A., Scragg R., Schwartz R.S., et al. Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older U.S. adults. J Am Geriatr Soc 2009, 57:1595-1603.
36. Kumar R., Tebben P.J., Thompson J.R. Vitamin D and the kidney. Arch Biochem Biophys 2012, 523:77-86.
37. Kandula P., Dobre M., Schold J.D., et al. Vitamin D supplementation in chronic kidney disease: a systematic review and meta-analysis of observational studies and randomized controlled trials. Clin J Am Soc Nephrol 2011, 6:50-62.
38. Skaaby T., Husemoen L.L., Pisinger C., et al. Vitamin D status and 5-year changes in urine albumin creatinine ratio and parathyroid hormone in a general population. Endocrine 2013, 44:473-480.
39. Earthman C.P., Beckman L.M., Masodkar K., et al. The link betweenobesity and low circulating 25-hydroxyvitamin D concentrations:considerations and implications. Int J Obes (Lond) 2012, 36:387-396.
40. Wortsman J., Matsuoka L.Y., Chen T.C., et al. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 2000, 72:690-693.